Safety of adjunctive perampanel by titration/maintenance periods and dose in patients with focal-onset seizures: Post hoc analysis of the FAME study

被引：0
|
作者：
Kim, Dong Wook [1 ]
Kim, Ji Hyun [2 ]
Dash, Amitabh [3 ]
Lee, JiWoong [4 ]
Malhotra, Manoj [5 ]
机构：
[1] Konkuk Univ, Sch Med, Seoul, South Korea
[2] Korea Univ, Guro Hosp, Seoul, South Korea
[3] Eisai Singapore Pte Ltd, Singapore, Singapore
[4] Eisai Korea Inc, Seoul, South Korea
[5] Eisai Inc, Woodcliff Lake, NJ USA
来源：
EPILEPSIA | 2021年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
128
引用
收藏
页码：43 / 44
页数：2
相关论文
共 50 条
  • [1] Efficacy/Safety of Low-/High-Dose Perampanel as First Adjunctive Therapy in Patients With Focal-Onset Seizures: Post Hoc Analysis of the FAME Study
    Seo, Dae Won
    Lee, JiWoong
    Dash, Amitabh
    Lee, Sang Kun
    Lee, Sang-Ahm
    Malhotra, Manoj
    EPILEPSIA, 2021, 62 : 51 - 51
  • [2] Efficacy and Safety of Perampanel in Patients with Focal-Onset Seizures (FOS): Post Hoc Analysis of FAME by Dose and First-Line Antiepileptic Drug
    Kim, Min Young
    Malhotra, Manoj
    Dash, Amitabh
    Lee, JiWoong
    EPILEPSIA, 2021, 62 : 40 - 41
  • [3] FAME study: Efficacy and safety of perampanel as first adjunctive therapy after first or second monotherapy in patients with focal-onset seizures
    Kim, Ji Hyun
    Kim, Dong Wook
    Dash, Amitabh
    Lee, JiWoong
    Malhotra, Manoj
    EPILEPSIA, 2021, 62 : 43 - 43
  • [4] Perampanel Monotherapy Beyond Initial Titration to Achieve Seizure Freedom in Patients with Focal-Onset Seizures: Post Hoc Analysis of Study 342
    Husni, Ryan Edbert
    Ngo, Leock Y.
    Patten, Anna
    Hiramatsu, Hidetaka
    Watanabe, Kazuaki
    Senokuchi, Hirofumi
    Yamamoto, Takamichi
    EPILEPSIA, 2021, 62 : 54 - 55
  • [5] Clinical Factors Associated with Response to Perampanel as First Adjunctive Treatment in Patients with Focal-Onset Seizures (FOS) in the FAME study
    Lee, JiWoong
    Kim, Dong Wook
    Seo, Dae Won
    Dash, Amitabh
    Malhotra, Manoj
    EPILEPSIA, 2021, 62 : 52 - 52
  • [6] The efficacy and safety of adjunctive perampanel for the treatment of refractory focal-onset seizures in patients with epilepsy: A meta-analysis
    Li, Yiming
    Zeng, Ya
    Mu, Jie
    Zhou, Dong
    EPILEPSIA OPEN, 2022, 7 (02) : 271 - 279
  • [7] Efficacy and Tolerability of Perampanel as Adjunctive Therapy in Chinese Patients With Focal-Onset Seizures: An Observational, Prospective Study
    Zhang, Ranran
    Qiao, Shan
    Fang, Xiqin
    Wang, Kemo
    Shi, Yanting
    Du, Qianwen
    Yang, Tingting
    Liu, Xuewu
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [8] Efficacy and Safety of Low- and High-Dose Perampanel as First Adjunctive Therapy in Patients With Partial-Onset Seizures (POS) With or Without Secondarily Generalized Seizures (SGS): Post Hoc Analysis of the FAME Study
    Seo, Dae Won
    Lee, Ji Woong
    Dash, Amitabh
    Lee, Sang Kun
    Lee, Sang Ahm
    Malhotra, Manoj
    NEUROLOGY, 2021, 96 (15)
  • [9] Effect of low dose (4 mg/day) perampanel on efficacy and safety outcomes from a mirroring clinical practice study of adjunctive perampanel in adults and adolescents with focal-onset seizures
    Giallonardo, A. T.
    Aguglia, U.
    Goldman, S.
    Chiacchiaretta, M.
    Gentile, A.
    Patten, A.
    EPILEPSIA, 2022, 63 : 128 - 129
  • [10] Seizure freedom in patients with focal to bilateral tonic-clonic seizures (FBTCS) during FAME: A post hoc analysis of low-dose maintenance perampanel
    Lee, Sang Kun
    Malhotra, Manoj
    Seo, Dae Won
    Lee, Sang-Ahm
    Dash, Amitabh
    Lee, JiWoong
    EPILEPSIA, 2021, 62 : 49 - 49
12345